·
4 Min Read

June 14, 2019: State Advocacy Update

Physicians take steps against opioid epidemic and Vermont removes prior authorization requirements for MAT in the latest AMA state advocacy news.

Advocacy Update
Delegates at the AMA Annual Meeting
·
3 Min Read

Get rid of market barriers to appropriate pain management

Health insurers, pharmacy benefit management companies and others are making it harder for physicians to provide appropriate care to patients living with pain.

Behavioral Health
·
4 Min Read

AMA passes opioid policies to end barriers to non-opioid treatment

The AMA approved several opioid-related policies intended to put the focus of pain treatment back on patients and away from arbitrary third-party controls.

Press Releases
Naloxone injector.
·
2 Min Read

Lifesaving naloxone should be available almost everywhere

Publicly available naloxone rescue boxes could allow bystanders to save the lives of people experiencing opioid overdoses.

Behavioral Health
·
3 Min Read

AMA strengthens its policies promoting naloxone access and education

Physicians and medical students acted today to strengthen existing AMA policy promoting increased access to naloxone, the opioid overdose-reversing drug.

Press Releases
·
4 Min Read

Physicians take steps against opioid epidemic, mortality rises

AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.

Press Releases
·
3 Min Read

Doctors make progress on opioids, call on policymakers to do more 

Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment. 

Behavioral Health
·
3 Min Read

May 31, 2019: Advocacy spotlight on AMA Opioid Task Force recommendations offer roadmap to policymakers

AMA Opioid Task Force recommendations offer roadmap to policymakers. Learn more about AMA's fight in the opioid epidemic.

Advocacy Update
·
7 Min Read

May 31, 2019: National Advocacy Update

Surprise billing proposals in Congress, Part D and Medicare Advantage drug pricing and more in the latest AMA national health care advocacy news.

Advocacy Update